Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye
Abstract Background Alpha-1 antitrypsin deficiency (AATD) is associated with increased susceptibility to chronic obstructive pulmonary disease (COPD). AATD results from mutations in the SERPINA1 gene and over 500 rare mutations have been identified. Despite these findings and recommendations from ma...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | BMC Pulmonary Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12890-024-03421-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850100637181673472 |
|---|---|
| author | Dilek Karadoğan Bettina Dreger Lourdes Osaba Enes Ahmetoğlu Songül Özyurt Bilge Yılmaz Kara Nur Hürsoy Tahsin Gökhan Telatar Ünal Şahin |
| author_facet | Dilek Karadoğan Bettina Dreger Lourdes Osaba Enes Ahmetoğlu Songül Özyurt Bilge Yılmaz Kara Nur Hürsoy Tahsin Gökhan Telatar Ünal Şahin |
| author_sort | Dilek Karadoğan |
| collection | DOAJ |
| description | Abstract Background Alpha-1 antitrypsin deficiency (AATD) is associated with increased susceptibility to chronic obstructive pulmonary disease (COPD). AATD results from mutations in the SERPINA1 gene and over 500 rare mutations have been identified. Despite these findings and recommendations from major healthcare organizations, testing of COPD patients and their family members for AATD remains inadequate. Methods We examined genotypes and clinical characteristics of COPD patients (index cases; n = 14) treated at Recep Tayyip Erdoğan University Chest Diseases Department and their relatives (n = 17). Results When index cases were compared with screened relatives positive for AATD (n = 14), index cases were older and more predominantly male than screened relatives. Both groups had extensive smoking histories. All of the index cases and one of the screened relatives had been diagnosed with COPD. Clinical characterization of the COPD cases (14 index cases; 1 screened relative) showed that they had moderate to severe COPD with pre-treatment AAT levels of 0.59 ± 0.40 g/L (mean ± SD) and a COPD Assessment Test (CAT) score of 16.0 ± 8.12. The majority of these patients (73.3%) had panlobular emphysema. Five of the patients were treated with AAT augmentation which led to a decrease in the number of COPD exacerbations. Genotyping revealed that the most common rare allele identified in this population was MPalermo (c.227_229delTCT mutation on the M1(Val213) allelic background). Conclusions More testing and research need to be done to identify the relative prevalence of rare AATD variants. Earlier identification could lead to more effective treatment of affected individuals and improvement in their quality of life. |
| format | Article |
| id | doaj-art-e4d5fe530aa24598b12f37612664eb53 |
| institution | DOAJ |
| issn | 1471-2466 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Pulmonary Medicine |
| spelling | doaj-art-e4d5fe530aa24598b12f37612664eb532025-08-20T02:40:14ZengBMCBMC Pulmonary Medicine1471-24662024-12-012411810.1186/s12890-024-03421-yClinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in TürkiyeDilek Karadoğan0Bettina Dreger1Lourdes Osaba2Enes Ahmetoğlu3Songül Özyurt4Bilge Yılmaz Kara5Nur Hürsoy6Tahsin Gökhan Telatar7Ünal Şahin8School of Medicine, Department of Chest Diseases, Recep Tayyip Erdoğan UniversityPulmonology Medical Affairs, Grifols Deutschland GmbHProgenika Biopharma, a Grifols companySchool of Medicine, Department of Chest Diseases, Recep Tayyip Erdoğan UniversitySchool of Medicine, Department of Chest Diseases, Recep Tayyip Erdoğan UniversitySchool of Medicine, Department of Chest Diseases, Recep Tayyip Erdoğan UniversitySchool of Medicine, Department of Radiology, Recep Tayyip Erdoğan UniversitySchool of Medicine, Department of Public Health, Recep Tayyip Erdoğan UniversitySchool of Medicine, Department of Chest Diseases, Recep Tayyip Erdoğan UniversityAbstract Background Alpha-1 antitrypsin deficiency (AATD) is associated with increased susceptibility to chronic obstructive pulmonary disease (COPD). AATD results from mutations in the SERPINA1 gene and over 500 rare mutations have been identified. Despite these findings and recommendations from major healthcare organizations, testing of COPD patients and their family members for AATD remains inadequate. Methods We examined genotypes and clinical characteristics of COPD patients (index cases; n = 14) treated at Recep Tayyip Erdoğan University Chest Diseases Department and their relatives (n = 17). Results When index cases were compared with screened relatives positive for AATD (n = 14), index cases were older and more predominantly male than screened relatives. Both groups had extensive smoking histories. All of the index cases and one of the screened relatives had been diagnosed with COPD. Clinical characterization of the COPD cases (14 index cases; 1 screened relative) showed that they had moderate to severe COPD with pre-treatment AAT levels of 0.59 ± 0.40 g/L (mean ± SD) and a COPD Assessment Test (CAT) score of 16.0 ± 8.12. The majority of these patients (73.3%) had panlobular emphysema. Five of the patients were treated with AAT augmentation which led to a decrease in the number of COPD exacerbations. Genotyping revealed that the most common rare allele identified in this population was MPalermo (c.227_229delTCT mutation on the M1(Val213) allelic background). Conclusions More testing and research need to be done to identify the relative prevalence of rare AATD variants. Earlier identification could lead to more effective treatment of affected individuals and improvement in their quality of life.https://doi.org/10.1186/s12890-024-03421-yAlpha-1 antitrypsin deficiencyMPalermoMMaltonCOPDScreeningTobacco |
| spellingShingle | Dilek Karadoğan Bettina Dreger Lourdes Osaba Enes Ahmetoğlu Songül Özyurt Bilge Yılmaz Kara Nur Hürsoy Tahsin Gökhan Telatar Ünal Şahin Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye BMC Pulmonary Medicine Alpha-1 antitrypsin deficiency MPalermo MMalton COPD Screening Tobacco |
| title | Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye |
| title_full | Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye |
| title_fullStr | Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye |
| title_full_unstemmed | Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye |
| title_short | Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye |
| title_sort | clinical implications of the serpina1 variant mpalermo and alpha 1 antitrypsin deficiency in turkiye |
| topic | Alpha-1 antitrypsin deficiency MPalermo MMalton COPD Screening Tobacco |
| url | https://doi.org/10.1186/s12890-024-03421-y |
| work_keys_str_mv | AT dilekkaradogan clinicalimplicationsoftheserpina1variantmpalermoandalpha1antitrypsindeficiencyinturkiye AT bettinadreger clinicalimplicationsoftheserpina1variantmpalermoandalpha1antitrypsindeficiencyinturkiye AT lourdesosaba clinicalimplicationsoftheserpina1variantmpalermoandalpha1antitrypsindeficiencyinturkiye AT enesahmetoglu clinicalimplicationsoftheserpina1variantmpalermoandalpha1antitrypsindeficiencyinturkiye AT songulozyurt clinicalimplicationsoftheserpina1variantmpalermoandalpha1antitrypsindeficiencyinturkiye AT bilgeyılmazkara clinicalimplicationsoftheserpina1variantmpalermoandalpha1antitrypsindeficiencyinturkiye AT nurhursoy clinicalimplicationsoftheserpina1variantmpalermoandalpha1antitrypsindeficiencyinturkiye AT tahsingokhantelatar clinicalimplicationsoftheserpina1variantmpalermoandalpha1antitrypsindeficiencyinturkiye AT unalsahin clinicalimplicationsoftheserpina1variantmpalermoandalpha1antitrypsindeficiencyinturkiye |